You are here: Home > Report library > Strategy analysis > Datamonitor Psoriatic Arthritis KOL Interviews

Datamonitor Psoriatic Arthritis KOL Interviews

$599.00

Datamonitor Psoriatic Arthritis KOL Interviews

$599.00

Datamonitor interviewed three rheumatologists, two based in the US and one in the UK, to determine their current treatment practices and views on pipeline and marketed drugs for psoriatic arthritis. The three interviews were combined into a single report.

SKU: N/A

Publisher: Datamonitor Healthcare, Biomedtracker

Published: 06/12/2016
Number of pages: 33
Formats: PDF
  • Description

Datamonitor interviewed three rheumatologists, two based in the US and one in the UK, to determine their current treatment practices and views on pipeline and marketed drugs for psoriatic arthritis. The three interviews were combined into a single report.

 

Indications Covered:Psoriatic Arthritis (PA)

© Pharma Intelligence UK Ltd. This document is a licensed product and is not to be reproduced or redistributed

Do you have a subscription to Datamonitor Healthcare, Biomedtracker or Meddevicetracker? You may already have access to these reports, contact your account manager or email pharma@informabi.com for further help or assistance.

2016 Post-AHA Report Advanced Wound Care Products Market

Sign up to the Pharma Intelligence Report Store Newsletter to get the latest blogs, news, reports and discounts!

Pharma Intelligence
Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is Suite 1, 3rd Floor, 11 - 12 St. James's Square, London, England, SW1Y 4LB. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.
Call Back